CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
local anaesthetic injection +5 moredrug
Likely dose
Ropivacaine 0.2% (0.5 mL/kg, maximum 30 mL) and methylprednisolone acetate 1 mg/kg (maximum 40 mg) injected via ultrasound-guided nerve blockAI-extracted
Key inclusion· 3
  • Age 8 to 18 years
  • ASA physical status I or II
  • Able to use a standard 0–10 numeric pain scale
Key exclusion· 4
  • Infection at the proposed block site
  • Bleeding disorders
  • Allergy to ropivacaine or methylprednisolone
  • Refusal of nerve block or study enrollment

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03053401
NCT03053401N/ACompleted

Ultrasound Guided Single Shot Adductor Canal Block (ACB) Versus Single Shot Femoral Nerve Block (FNB) for Postoperative Analgesia After Arthroscopic Anterior Cruciate Ligament (ACL) Reconstruction in Pediatrics

Akron Children's Hospital·interventional·Posted Feb 15, 2017·Updated Dec 28, 2020

In Brief

A clinical study evaluating Adductor Canal Block, Femoral Nerve Block, and 4 other interventions for Post-operative Pain and Quadriceps Muscle Strength. Completed, enrolled 52 participants across 1 site.

Detailed Summary

Both Ultrasound guided Adductor Canal Block ( ACB) and Femoral Nerve Block (FNB) has been used to provide postoperative analgesia for knee surgeries. To the investigators' knowledge, no comparison has been made between those blocks in relation to postoperative quadriceps muscle strength, or duration and quality of postoperative analgesia for arthroscopic ACL reconstruction in pediatrics. If ACB provides postoperative analgesia after arthroscopic knee surgery comparable to FNB, it has the potential to improve the postoperative outcome as it will lead to less quadriceps muscle weakness and early mobilization, both of which are very important in the early postoperative period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 15, 2017
Enrollment StartFeb 9, 2017
Primary CompletionOct 25, 2019
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 9.4 years ago

Interventions

Adductor Canal Blockprocedure

Under guidance of a linear ultrasound transducer probe (General Electric; GE). Performed using a 22-gauge 2-inch Stimuplex A needle ( B. Braun Medical Inc., Melsungen, Germany).Solution to be injected will be a combination of Ropivacaine 0.2 % ( 0.5 ml/kg, maximum of 30 ml) and methylprednisolone acetate 1 mg/kg ( maximum of 40 mg ).

Femoral Nerve Blockprocedure

Under guidance of a linear ultrasound transducer probe (General Electric;GE).Block will be performed using a 22-gauge 2-inch Stimuplex A needle ( B. Braun Medical Inc., Melsungen, Germany).Solution to be injected will be a combination of Ropivacaine 0.2 % ( 0.5 ml/kg, maximum of 30 ml) and methylprednisolone acetate 1 mg/kg (maximum of 40 mg ).

Ultrasounddevice

Use of linear ultrasound transducer probe (General Electric;GE) to guide needle placement for both Adductor Canal Block and Femoral nerve Blocks

Stimuplex A needledevice

22-gauge 2-inch Stimuplex A needle ( B. Braun Medical Inc., Melsungen, Germany) used to perform both Adductor Canal Block and Femoral nerve Blocks.

local anaesthetic injectiondrug

Ropivacaine 0.2 % ( 0.5 ml/kg, maximum of 30 ml) for either Adductor Canal Block and Femoral nerve Blocks.

Steroid Drugdrug

Methylprednisolone acetate 1 mg/kg (maximum of 40 mg ) for either Adductor Canal Block and Femoral nerve Blocks.